APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pet Pharmaceuticals

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pet Pharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

29 December 2025199 pages

Choose your research edition.

Industry ResearchPet Pharmaceuticals Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Pet Pharmaceuticals Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Pet Pharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pet Pharmaceuticals Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Pet Pharmaceuticals Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Pet Pharmaceuticals market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pet Pharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pet Pharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pet Pharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pet Pharmaceuticals is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pet Pharmaceuticals include CAHIC, Chopperlvya Animal Health, Merck, Jindun, Zoetis, Virbac, Vetoquinol, Ouro Fino Saude and Norbrook, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pet Pharmaceuticals market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pet Pharmaceuticals and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pet Pharmaceuticals sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pet Pharmaceuticals market size, projected growth trends, production technologies, key applications, and end-use industries.

Pet Pharmaceuticals Segment by Company

CAHIC

Chopperlvya Animal Health

Merck

Jindun

Zoetis

Virbac

Vetoquinol

Ouro Fino Saude

Norbrook

Elanco

Dechra Veterinary Products

Ceva

Boehringer Ingelheim

Pet Pharmaceuticals Segment by Type

Antiparasitic

Antibacterial

Biological Products

Others

Pet Pharmaceuticals Segment by Application

Prevention

Treatment

Pet Pharmaceuticals Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Pharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Pharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Pharmaceuticals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pet Pharmaceuticals market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pet Pharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pet Pharmaceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pet Pharmaceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pet Pharmaceuticals Industry Trends Table 2. Pet Pharmaceuticals Industry Drivers Table 3. Pet Pharmaceuticals Industry Opportunities and Challenges Table 4. Pet Pharmaceuticals Industry Restraints Table 5. Global Pet Pharmaceuticals Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pet Pharmaceuticals Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pet Pharmaceuticals Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Pet Pharmaceuticals Sales Market Share by Manufacturers Table 9. Global Pet Pharmaceuticals Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Pet Pharmaceuticals Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pet Pharmaceuticals Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pet Pharmaceuticals Manufacturers, Product Type & Application Table 13. Global Pet Pharmaceuticals Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pet Pharmaceuticals by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Antiparasitic Table 17. Major Manufacturers of Antibacterial Table 18. Major Manufacturers of Biological Products Table 19. Major Manufacturers of Others Table 20. Global Pet Pharmaceuticals Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Pet Pharmaceuticals Sales by Type (2021-2026) & (K Units) Table 22. Global Pet Pharmaceuticals Sales by Type (2027-2032) & (K Units) Table 23. Global Pet Pharmaceuticals Sales Market Share by Type (2021-2026) Table 24. Global Pet Pharmaceuticals Sales Market Share by Type (2027-2032) Table 25. Global Pet Pharmaceuticals Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Pet Pharmaceuticals Revenue by Type (2021-2026) & (K Units) Table 27. Global Pet Pharmaceuticals Revenue by Type (2027-2032) & (K Units) Table 28. Global Pet Pharmaceuticals Revenue Market Share by Type (2021-2026) Table 29. Global Pet Pharmaceuticals Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Prevention Table 31. Major Manufacturers of Treatment Table 32. Global Pet Pharmaceuticals Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Pet Pharmaceuticals Sales by Application (2021-2026) & (K Units) Table 34. Global Pet Pharmaceuticals Sales by Application (2027-2032) & (K Units) Table 35. Global Pet Pharmaceuticals Sales Market Share by Application (2021-2026) Table 36. Global Pet Pharmaceuticals Sales Market Share by Application (2027-2032) Table 37. Global Pet Pharmaceuticals Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Pet Pharmaceuticals Revenue by Application (2021-2026) & (K Units) Table 39. Global Pet Pharmaceuticals Revenue by Application (2027-2032) & (K Units) Table 40. Global Pet Pharmaceuticals Revenue Market Share by Application (2021-2026) Table 41. Global Pet Pharmaceuticals Revenue Market Share by Application (2027-2032) Table 42. Global Pet Pharmaceuticals Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Pet Pharmaceuticals Sales by Region (2021-2026) & (K Units) Table 44. Global Pet Pharmaceuticals Sales Market Share by Region (2021-2026) Table 45. Global Pet Pharmaceuticals Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Pet Pharmaceuticals Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Pet Pharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Pet Pharmaceuticals Sales by Country (2021-2026) & (K Units) Table 49. North America Pet Pharmaceuticals Sales by Country (2027-2032) & (K Units) Table 50. Europe Pet Pharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Pet Pharmaceuticals Sales by Country (2021-2026) & (K Units) Table 52. Europe Pet Pharmaceuticals Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Pet Pharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Pet Pharmaceuticals Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Pet Pharmaceuticals Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Pet Pharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Pet Pharmaceuticals Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Pet Pharmaceuticals Sales by Country (2027-2032) & (K Units) Table 59. Global Pet Pharmaceuticals Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Pet Pharmaceuticals Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Pet Pharmaceuticals Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Pet Pharmaceuticals Revenue Market Share by Region (2021-2026) Table 63. Global Pet Pharmaceuticals Revenue Market Share by Region (2027-2032) Table 64. CAHIC Company Information Table 65. CAHIC Business Overview Table 66. CAHIC Pet Pharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. CAHIC Pet Pharmaceuticals Product Portfolio Table 68. CAHIC Recent Development Table 69. Chopperlvya Animal Health Company Information Table 70. Chopperlvya Animal Health Business Overview Table 71. Chopperlvya Animal Health Pet Pharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Chopperlvya Animal Health Pet Pharmaceuticals Product Portfolio Table 73. Chopperlvya Animal Health Recent Development Table 74. Merck Company Information Table 75. Merck Business Overview Table 76. Merck Pet Pharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Merck Pet Pharmaceuticals Product Portfolio Table 78. Merck Recent Development Table 79. Jindun Company Information Table 80. Jindun Business Overview Table 81. Jindun Pet Pharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Jindun Pet Pharmaceuticals Product Portfolio Table 83. Jindun Recent Development Table 84. Zoetis Company Information Table 85. Zoetis Business Overview Table 86. Zoetis Pet Pharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Zoetis Pet Pharmaceuticals Product Portfolio Table 88. Zoetis Recent Development Table 89. Virbac Company Information Table 90. Virbac Business Overview Table 91. Virbac Pet Pharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Virbac Pet Pharmaceuticals Product Portfolio Table 93. Virbac Recent Development Table 94. Vetoquinol Company Information Table 95. Vetoquinol Business Overview Table 96. Vetoquinol Pet Pharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Vetoquinol Pet Pharmaceuticals Product Portfolio Table 98. Vetoquinol Recent Development Table 99. Ouro Fino Saude Company Information Table 100. Ouro Fino Saude Business Overview Table 101. Ouro Fino Saude Pet Pharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Ouro Fino Saude Pet Pharmaceuticals Product Portfolio Table 103. Ouro Fino Saude Recent Development Table 104. Norbrook Company Information Table 105. Norbrook Business Overview Table 106. Norbrook Pet Pharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Norbrook Pet Pharmaceuticals Product Portfolio Table 108. Norbrook Recent Development Table 109. Elanco Company Information Table 110. Elanco Business Overview Table 111. Elanco Pet Pharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Elanco Pet Pharmaceuticals Product Portfolio Table 113. Elanco Recent Development Table 114. Dechra Veterinary Products Company Information Table 115. Dechra Veterinary Products Business Overview Table 116. Dechra Veterinary Products Pet Pharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Dechra Veterinary Products Pet Pharmaceuticals Product Portfolio Table 118. Dechra Veterinary Products Recent Development Table 119. Ceva Company Information Table 120. Ceva Business Overview Table 121. Ceva Pet Pharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Ceva Pet Pharmaceuticals Product Portfolio Table 123. Ceva Recent Development Table 124. Boehringer Ingelheim Company Information Table 125. Boehringer Ingelheim Business Overview Table 126. Boehringer Ingelheim Pet Pharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Boehringer Ingelheim Pet Pharmaceuticals Product Portfolio Table 128. Boehringer Ingelheim Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Pet Pharmaceuticals Distributors List Table 132. Pet Pharmaceuticals Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Pet Pharmaceuticals Product Image Figure 2. Global Pet Pharmaceuticals Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pet Pharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 4. Global Pet Pharmaceuticals Sales (2021-2032) & (K Units) Figure 5. Global Pet Pharmaceuticals Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Pet Pharmaceuticals Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Antiparasitic Image Figure 9. Antibacterial Image Figure 10. Biological Products Image Figure 11. Others Image Figure 12. Global Pet Pharmaceuticals Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Pet Pharmaceuticals Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Pet Pharmaceuticals Sales Market Share by Type (2021-2032) Figure 15. Global Pet Pharmaceuticals Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Pet Pharmaceuticals Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Pet Pharmaceuticals Revenue Market Share by Type (2021-2032) Figure 18. Prevention Image Figure 19. Treatment Image Figure 20. Global Pet Pharmaceuticals Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Pet Pharmaceuticals Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Pet Pharmaceuticals Sales Market Share by Application (2021-2032) Figure 23. Global Pet Pharmaceuticals Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Pet Pharmaceuticals Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Pet Pharmaceuticals Revenue Market Share by Application (2021-2032) Figure 26. North America Pet Pharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Pet Pharmaceuticals Sales Market Share by Country (2021-2032) Figure 28. U.S. Pet Pharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Pet Pharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Pet Pharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Pet Pharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Pet Pharmaceuticals Sales Market Share by Country (2021-2032) Figure 33. Germany Pet Pharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Pet Pharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Pet Pharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Pet Pharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Pet Pharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Pet Pharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Pet Pharmaceuticals Sales Market Share by Country (2021-2032) Figure 40. China Pet Pharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Pet Pharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Pet Pharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Pet Pharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Pet Pharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Pet Pharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Pet Pharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Pet Pharmaceuticals Sales Market Share by Country (2021-2032) Figure 48. Brazil Pet Pharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Pet Pharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Pet Pharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Pet Pharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Pet Pharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Pet Pharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Pet Pharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Pet Pharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Pet Pharmaceuticals Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Pet Pharmaceuticals Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Pet Pharmaceuticals Revenue (2021-2032) & (US$ Million) Figure 59. North America Pet Pharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Pet Pharmaceuticals Revenue (2021-2032) & (US$ Million) Figure 61. Europe Pet Pharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Pet Pharmaceuticals Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Pet Pharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Pet Pharmaceuticals Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Pet Pharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Pet Pharmaceuticals Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Pet Pharmaceuticals Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Antiparasitic
  • Antibacterial
  • Biological Products
  • Others
Applications
  • Prevention
  • Treatment
Companies covered
  • CAHIC
  • Chopperlvya Animal Health
  • Merck
  • Jindun
  • Zoetis
  • Virbac
  • Vetoquinol
  • Ouro Fino Saude
  • Norbrook
  • Elanco
  • Dechra Veterinary Products
  • Ceva
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pet Pharmaceuticals Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pet Pharmaceuticals Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pet Pharmaceuticals Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pet Pharmaceuticals Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pet Pharmaceuticals Market Dynamics
  1. 2.1 Pet Pharmaceuticals Industry Trends
  2. 2.2 Pet Pharmaceuticals Industry Drivers
  3. 2.3 Pet Pharmaceuticals Industry Opportunities and Challenges
  4. 2.4 Pet Pharmaceuticals Industry Restraints
3 Pet Pharmaceuticals Market by Manufacturers
  1. 3.1 Global Pet Pharmaceuticals Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pet Pharmaceuticals Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pet Pharmaceuticals Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pet Pharmaceuticals Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pet Pharmaceuticals Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pet Pharmaceuticals Manufacturers, Product Type & Application
  7. 3.7 Global Pet Pharmaceuticals Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pet Pharmaceuticals Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pet Pharmaceuticals Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pet Pharmaceuticals Tier 1, Tier 2, and Tier 3
4 Pet Pharmaceuticals Market by Type
  1. 4.1 Pet Pharmaceuticals Type Introduction
  2. 4.1.1 Antiparasitic
  3. 4.1.2 Antibacterial
  4. 4.1.3 Biological Products
  5. 4.1.4 Others
  6. 4.2 Global Pet Pharmaceuticals Sales by Type
  7. 4.2.1 Global Pet Pharmaceuticals Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Pet Pharmaceuticals Sales by Type (2021-2032)
  9. 4.2.3 Global Pet Pharmaceuticals Sales Market Share by Type (2021-2032)
  10. 4.3 Global Pet Pharmaceuticals Revenue by Type
  11. 4.3.1 Global Pet Pharmaceuticals Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Pet Pharmaceuticals Revenue by Type (2021-2032)
  13. 4.3.3 Global Pet Pharmaceuticals Revenue Market Share by Type (2021-2032)
5 Pet Pharmaceuticals Market by Application
  1. 5.1 Pet Pharmaceuticals Application Introduction
  2. 5.1.1 Prevention
  3. 5.1.2 Treatment
  4. 5.2 Global Pet Pharmaceuticals Sales by Application
  5. 5.2.1 Global Pet Pharmaceuticals Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Pet Pharmaceuticals Sales by Application (2021-2032)
  7. 5.2.3 Global Pet Pharmaceuticals Sales Market Share by Application (2021-2032)
  8. 5.3 Global Pet Pharmaceuticals Revenue by Application
  9. 5.3.1 Global Pet Pharmaceuticals Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Pet Pharmaceuticals Revenue by Application (2021-2032)
  11. 5.3.3 Global Pet Pharmaceuticals Revenue Market Share by Application (2021-2032)
6 Global Pet Pharmaceuticals Sales by Region
  1. 6.1 Global Pet Pharmaceuticals Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pet Pharmaceuticals Sales by Region (2021-2032)
  3. 6.2.1 Global Pet Pharmaceuticals Sales by Region (2021-2026)
  4. 6.2.2 Global Pet Pharmaceuticals Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pet Pharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pet Pharmaceuticals Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pet Pharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pet Pharmaceuticals Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pet Pharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pet Pharmaceuticals Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pet Pharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pet Pharmaceuticals Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pet Pharmaceuticals Revenue by Region
  1. 7.1 Global Pet Pharmaceuticals Revenue by Region
  2. 7.1.1 Global Pet Pharmaceuticals Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pet Pharmaceuticals Revenue by Region (2021-2026)
  4. 7.1.3 Global Pet Pharmaceuticals Revenue by Region (2027-2032)
  5. 7.1.4 Global Pet Pharmaceuticals Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pet Pharmaceuticals Revenue (2021-2032)
  8. 7.2.2 North America Pet Pharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pet Pharmaceuticals Revenue (2021-2032)
  11. 7.3.2 Europe Pet Pharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pet Pharmaceuticals Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pet Pharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pet Pharmaceuticals Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pet Pharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 CAHIC
  2. 8.1.1 CAHIC Company Information
  3. 8.1.2 CAHIC Business Overview
  4. 8.1.3 CAHIC Pet Pharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CAHIC Pet Pharmaceuticals Product Portfolio
  6. 8.1.5 CAHIC Recent Developments
  7. 8.2 Chopperlvya Animal Health
  8. 8.2.1 Chopperlvya Animal Health Company Information
  9. 8.2.2 Chopperlvya Animal Health Business Overview
  10. 8.2.3 Chopperlvya Animal Health Pet Pharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Chopperlvya Animal Health Pet Pharmaceuticals Product Portfolio
  12. 8.2.5 Chopperlvya Animal Health Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Pet Pharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Pet Pharmaceuticals Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Jindun
  20. 8.4.1 Jindun Company Information
  21. 8.4.2 Jindun Business Overview
  22. 8.4.3 Jindun Pet Pharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Jindun Pet Pharmaceuticals Product Portfolio
  24. 8.4.5 Jindun Recent Developments
  25. 8.5 Zoetis
  26. 8.5.1 Zoetis Company Information
  27. 8.5.2 Zoetis Business Overview
  28. 8.5.3 Zoetis Pet Pharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Zoetis Pet Pharmaceuticals Product Portfolio
  30. 8.5.5 Zoetis Recent Developments
  31. 8.6 Virbac
  32. 8.6.1 Virbac Company Information
  33. 8.6.2 Virbac Business Overview
  34. 8.6.3 Virbac Pet Pharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Virbac Pet Pharmaceuticals Product Portfolio
  36. 8.6.5 Virbac Recent Developments
  37. 8.7 Vetoquinol
  38. 8.7.1 Vetoquinol Company Information
  39. 8.7.2 Vetoquinol Business Overview
  40. 8.7.3 Vetoquinol Pet Pharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Vetoquinol Pet Pharmaceuticals Product Portfolio
  42. 8.7.5 Vetoquinol Recent Developments
  43. 8.8 Ouro Fino Saude
  44. 8.8.1 Ouro Fino Saude Company Information
  45. 8.8.2 Ouro Fino Saude Business Overview
  46. 8.8.3 Ouro Fino Saude Pet Pharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Ouro Fino Saude Pet Pharmaceuticals Product Portfolio
  48. 8.8.5 Ouro Fino Saude Recent Developments
  49. 8.9 Norbrook
  50. 8.9.1 Norbrook Company Information
  51. 8.9.2 Norbrook Business Overview
  52. 8.9.3 Norbrook Pet Pharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Norbrook Pet Pharmaceuticals Product Portfolio
  54. 8.9.5 Norbrook Recent Developments
  55. 8.10 Elanco
  56. 8.10.1 Elanco Company Information
  57. 8.10.2 Elanco Business Overview
  58. 8.10.3 Elanco Pet Pharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Elanco Pet Pharmaceuticals Product Portfolio
  60. 8.10.5 Elanco Recent Developments
  61. 8.11 Dechra Veterinary Products
  62. 8.11.1 Dechra Veterinary Products Company Information
  63. 8.11.2 Dechra Veterinary Products Business Overview
  64. 8.11.3 Dechra Veterinary Products Pet Pharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Dechra Veterinary Products Pet Pharmaceuticals Product Portfolio
  66. 8.11.5 Dechra Veterinary Products Recent Developments
  67. 8.12 Ceva
  68. 8.12.1 Ceva Company Information
  69. 8.12.2 Ceva Business Overview
  70. 8.12.3 Ceva Pet Pharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Ceva Pet Pharmaceuticals Product Portfolio
  72. 8.12.5 Ceva Recent Developments
  73. 8.13 Boehringer Ingelheim
  74. 8.13.1 Boehringer Ingelheim Company Information
  75. 8.13.2 Boehringer Ingelheim Business Overview
  76. 8.13.3 Boehringer Ingelheim Pet Pharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Boehringer Ingelheim Pet Pharmaceuticals Product Portfolio
  78. 8.13.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pet Pharmaceuticals Value Chain Analysis
  2. 9.1.1 Pet Pharmaceuticals Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pet Pharmaceuticals Production Mode & Process
  6. 9.2 Pet Pharmaceuticals Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pet Pharmaceuticals Distributors
  9. 9.2.3 Pet Pharmaceuticals Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst